Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in mice - Archive ouverte HAL Accéder directement au contenu
Pré-Publication, Document De Travail Année : 2022

Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in mice

K. Polak
N. Greze
  • Fonction : Auteur
M. Lachat
  • Fonction : Auteur
D. Merle
  • Fonction : Auteur
S. Chiumento
B. Trentin
  • Fonction : Auteur
R. Mamoun
  • Fonction : Auteur

Résumé

Extracellular vesicles (EVs) emerge as essential mediators of intercellular communication. DNA vaccines encoding antigens presented on EVs efficiently induce T-cell responses and EV-based vaccines containing the Spike (S) proteins of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) are highly immunogenic in mice. Thus, EVs may serve as vaccine platforms against emerging diseases, going beyond traditional strategies, with the antigen displayed identically to the original protein embedded in the viral membrane and presented as such to the immune system. Compared to their viral and pseudotyped counterparts, EV-based vaccines overcome many safety issues including pre-existing immunity against these vectors. Here, we applied our technology in natural EV’s engineering, to express the S proteins of SARS-CoV-2 embedded in the EVs, which mimic the virus with its fully native spikes. Immunizations with a two component CoVEVax vaccine, comprising DNA vector (DNA S-EV ) primes, allowing in situ production of Spike harbouring EVs, and a boost using S-EVs produced in mammalian cells, trigger potent neutralizing and cellular responses in mice, in the absence of any adjuvants. CoVEVax would be the prototype of vaccines, where the sole exchange of the envelope proteins on EVs leads to the generation of new vaccine candidates against emerging viruses.

Dates et versions

hal-03514469 , version 1 (06-01-2022)

Identifiants

Citer

K. Polak, N. Greze, M. Lachat, D. Merle, S. Chiumento, et al.. Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in mice. 2022. ⟨hal-03514469⟩
136 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More